Antithesis's last reported valuation, Feb 2024. Nothing priced has surfaced since.
- ·The complete investor list: 23 names
- ·Watch Antithesis: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Antithesis funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Later Stage VC (Series A) | $105.0M | ▮ | ▮ |
| Feb 2024 | Seed Round | $47.0M | ▮ | ▮ |
Membership and data by Private Market View
Antithesis valuation
Antithesis's last reported valuation was $215 million in Feb 2024. No priced round, secondary trade or fund mark has surfaced since.
How much has Antithesis raised?
Antithesis has raised $160 million across 2 recorded rounds since 2024. The largest was a $47 million seed round in Feb 2024; the most recent was a $105 million Series A in Dec 2025.
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy Antithesis shares, reporting $106,331 sold to 2 investors, per SEC Form D filings (most recent Mar 2026).
Comparable companies
Comparable business/productivity software names by valuation on PrivateMarketView: NetBox Labs ($215 million), Regrow ($210 million) and Ema Unlimited ($207 million).
How Antithesis's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Antithesis, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Antithesis
- What is Antithesis worth?
- Antithesis is valued at $215.0M as of Oct 2026. Antithesis's last reported valuation, Feb 2024. Nothing priced has surfaced since.
- How much has Antithesis raised?
- Antithesis has raised $160.0M in total funding across 2 recorded rounds.
- When did Antithesis last raise?
- Antithesis last raised in Dec 2025 (Later Stage VC (Series A)), raising $105.0M.